In his most recent financial disclosure report, Rep. John Yarmuth (D-Louisville) said he’d bought stock in 23 companies, including four expected to grow faster than sleepy “widow and orphan” stocks. But they can also be more risky; high flyers can go way down, too.
The report doesn’t disclose exactly what Yarmuth paid per share, nor how much he invested, only valuing the stakes in the range of $1,000 to $15,000 each. Still, we can get a glimpse at their performance by comparing their closing price on the date of the report to Friday’s closing price.
His results were mixed: The best performer was Facebook, and the worst was Irish drugmaker Allergan. We’ve thrown in the S&P 500 index for comparison.
Related: Search for more congressional financial disclosure reports. And follow Boulevard’s stock portfolio of big Louisville employers.
Boulevard 